Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

ITRM

Insider Sentiment (TTM):

Last Purchase:2025-11-18Last Sale:2022-12-02Shares Purchased (TTM):6,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:1,407,303Shares Outstanding:45,801,927Institutional Ownership Pct.:3.07%

Earnings Market Reaction:

Filing Date:2025-11-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	11	13	13	24	13	5	7	6	5	14	17	21
Short Term Investments	-	-	-	0	1	7	11	18	31	31	35	40
Accounts Receivable Net Current	0	-	-	-	-	-	-	-	-	-	-	-
Inventory Net	1	1	1	-	-	-	-	-	-	-	-	-
Income Taxes Receivable	0	0	0	0	0	0	-	0	-	0	0	0
Prepaid Expense And Other Assets Current	1	1	0	1	1	2	1	2	3	3	2	1
Assets Current	14	15	14	25	16	14	19	26	39	48	54	62
Intangible Assets Net Excluding Goodwill	19	19	19	20	-	-	-	-	0	1	1	2
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Restricted Cash And Cash Equivalents Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	0	0	0	0	0	0	0	1	1	2	2	3
Assets	33	34	33	45	16	14	20	26	40	51	58	67
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	0	0	1	1	3	5	6	4	2	3
Accrued Liabilities Current	5	4	3	3	3	2	2	8	9	5	4	4
Derivative Liabilities Current	-	-	-	-	-	-	-	-	0	0	0	0
Convertible Debt Current	0	0	0	14	14	13	12	-	-	-	-	-
Taxes Payable Current	0	0	0	-	-	-	0	-	0	-	-	-
Other Liabilities Current	0	0	0	0	1	1	1	1	2	2	2	2
Liabilities Current	6	6	4	18	19	17	18	14	16	11	8	9
Convertible Debt Noncurrent	-	-	-	-	-	-	-	11	-	-	-	-
Long Term Debt Noncurrent	-	-	-	-	-	-	-	11	12	12	11	10
Other Liabilities Noncurrent	-	-	-	0	-	0	0	0	0	1	1	1
Liabilities	40	38	36	49	27	25	26	33	36	44	39	39
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	499	493	488	482	468	462	462	455	452	452	452	451
Retained Earnings Accumulated Deficit	-506	-497	-491	-486	-479	-473	-468	-461	-449	-445	-433	-423
Accumulated Other Comprehensive Income Loss Net Of…	-	0	0	0	0	-0	-	0	0	-0	-0	-0
Stockholders Equity	-7	-4	-3	-4	-12	-11	-6	-6	3	7	19	28
Liabilities And Stockholders Equity	33	34	33	45	16	14	20	26	40	51	58	67
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	80	80	80	80	80	80	80	80	80	80	20	20
Common Stock Shares Issued	49	42	36	32	23	17	16	13	13	13	13	13

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	3.37%	2.72%	-21.99%	-2.67%	3.52%	-0.12%	0.40%	-33.10%	-34.69%	-	-	-
2024	-9.21%	-24.34%	-21.05%	-10.74%	-16.94%	0.83%	98.53%	39.71%	17.65%	-2.45%	-11.89%	-11.89%
2023	6.14%	-6.14%	-7.89%	-18.37%	-26.51%	-38.53%	120.89%	154.43%	98.73%	-7.14%	-8.44%	-25.32%
2022	-	-	-	-	-	-	-	-	-	-15.63%	-2.61%	5.22%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Liquidity Ratios
Current Ratio	2.13	2.69	3.72	1.41	0.85	0.82	1.07	1.89	2.35	4.40	6.96	6.89
Quick Ratio	1.78	2.35	3.49	1.37	0.79	0.71	1.02	1.77	2.19	4.13	6.67	6.74
Working Capital	7.30M	9.36M	9.89M	7.18M	-2.85M	-3.08M	1.26M	12.08M	22.13M	36.82M	46.45M	53.38M
Leverage & Debt
Debt to Equity	-5.40	-9.75	-13.91	-11.93	-2.38	-2.30	-4.19	-5.10	10.58	6.16	2.07	1.39
Interest Coverage TTM	-20.12	-23.23	-25.78	-25.86	-35.85	-50.20	-57.31	-58.53	-35.77	-20.67	-14.20	-13.68
Debt Ratio	1.23	1.11	1.08	1.09	1.72	1.77	1.31	1.24	0.91	0.86	0.67	0.58
Efficiency & Turnover
Asset Turnover TTM	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding TTM	419.28	-	-	-	-	-	-	-	-	-	-	-
Receivables Turnover TTM	0.87	-	-	-	-	-	-	-	-	-	-	-
Per Share Metrics
Diluted EPS TTM	-0.59	-0.60	-0.66	-1.26	-1.52	-1.71	-2.31	-2.96	-2.38	-4.35	-4.01	-3.63
Free Cash Flow Per Share TTM	-0.43	-0.37	-0.49	-1.36	-1.76	-2.53	-2.78	-3.04	-2.36	-2.02	-1.95	-1.51
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-5,292.31%	-	-	-	-	-	-	-	-	-	-	-
Net Profit Margin TTM	-6,913.08%	-	-	-	-	-	-	-	-	-	-	-
Growth Metrics
Net Income Growth (1Y)	-11.76%	-15.04%	-36.59%	-35.44%	-1.75%	-49.70%	-29.99%	-13.64%	-28.55%	427.64%	-1,417.68%	-51.47%
EPS Growth (1Y)	-61.38%	-64.78%	-71.27%	-57.52%	-36.09%	-60.66%	-42.47%	-18.48%	-32.97%	398.34%	-1,366.93%	-56.81%
Calculated Values
Free Cash Flow TTM	-19.53M	-14.74M	-16.75M	-26.77M	-35.36M	-41.96M	-42.84M	-39.35M	-30.82M	-26.09M	-24.72M	-18.54M
Net Debt	-11.00M	-13.03M	-12.65M	-9.66M	302.00K	7.98M	4.81M	5.38M	7.65M	-2.07M	-5.95M	-11.00M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-18Purchase

Owner: Dunne, Michael W.

Title: -

Shares: 6,000

Price/Share: $0.37

Value: $2,220.00

Shares Owned: 241,001

Relationship: Director

Ownership: Direct

2025-08-08Purchase

Owner: Dunne, Michael W.

Title: -

Shares: 15,000

Price/Share: $0.72

Value: $10,800.00

Shares Owned: 235,001

Relationship: Director

Ownership: Direct

2023-12-22Purchase

Owner: Dunne, Michael W.

Title: -

Shares: 25,000

Price/Share: $1.40

Value: $35,000.00

Shares Owned: 113,754

Relationship: Director

Ownership: Direct

2023-12-18Purchase

Owner: Dunne, Michael W.

Title: -

Shares: 10,000

Price/Share: $1.84

Value: $18,400.00

Shares Owned: 88,754

Relationship: Director

Ownership: Direct

2023-11-22Purchase

Owner: Dunne, Michael W.

Title: -

Shares: 20,000

Price/Share: $2.03

Value: $40,600.00

Shares Owned: 78,754

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-18	Dunne, Michael W.	Director	-	Direct	Purchase	6,000	0.37	$2,220.00	241,001	4
2025-08-08	Dunne, Michael W.	Director	-	Direct	Purchase	15,000	0.72	$10,800.00	235,001	4
2023-12-22	Dunne, Michael W.	Director	-	Direct	Purchase	25,000	1.40	$35,000.00	113,754	4
2023-12-18	Dunne, Michael W.	Director	-	Direct	Purchase	10,000	1.84	$18,400.00	88,754	4
2023-11-22	Dunne, Michael W.	Director	-	Direct	Purchase	20,000	2.03	$40,600.00	78,754	4
2023-11-20	Fishman, Corey N.	Director,Officer	Chief Executive Officer	Direct	Purchase	10,000	1.59	$15,900.00	54,449	4
2022-12-02	Puttagunta, Sailaja	Officer	Chief Medical Officer	Direct	Sale	3,365	1.32	$4,441.80	4,969	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

3.07%

Inst. Shares: 1,407,303

Shares Outstanding: 45,801,927

2025-09-30

2.34%

Inst. Shares: 1,073,043

Shares Outstanding: 45,801,927

2025-06-30

5.71%

Inst. Shares: 2,279,284

Shares Outstanding: 39,935,213

2025-03-31

3.02%

Inst. Shares: 1,026,920

Shares Outstanding: 34,059,630

2024-12-31

5.94%

Inst. Shares: 1,169,934

Shares Outstanding: 19,699,260

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	1,407,303	45,801,927	3.07%
2025-09-30	1,073,043	45,801,927	2.34%
2025-06-30	2,279,284	39,935,213	5.71%
2025-03-31	1,026,920	34,059,630	3.02%
2024-12-31	1,169,934	19,699,260	5.94%
2024-09-30	2,040,704	20,044,270	10.18%
2024-06-30	431,582	16,552,214	2.61%
2024-03-31	818,265	15,432,693	5.30%
2023-12-31	336,614	12,962,362	2.60%
2023-09-30	179,856	13,039,437	1.38%
2023-06-30	399,626	12,942,969	3.09%
2023-03-31	138,207	12,681,900	1.09%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Iterum Therapeutics plc (ITRM) — SEC Financial Statements & Analysis

Iterum Therapeutics plc (ITRM) is a pharmaceutical preparations company, incorporated in L2. Iterum Therapeutics plc trades on Nasdaq as: ITRM. Based on its latest SEC filing (Form 10-Q, period ending 2025-09-30), Iterum Therapeutics plc reported a Debt-to-Equity ratio of -5.40x. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: -5.40x

Data as of 2025-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Iterum Therapeutics plc in?

Iterum Therapeutics plc (ITRM) operates in the Pharmaceutical Preparations industry.

What exchange does ITRM trade on?

Iterum Therapeutics plc (ITRM) trades on the Nasdaq.

Where is Iterum Therapeutics plc incorporated?

Iterum Therapeutics plc is incorporated in Ireland.